Emily Field, head of European pharmaceuticals research at Barclays, weighs in on rising competition in the global obesity ...
CNBC’s Deirdre Bosa, Big Technology’s Alex Kantrowitz and Wealth Enhancement’s Ayako Yoshioka, join 'Closing Bell' to discuss ...
Merck's latest earnings call revealed a mix of growth and pain points for the pharmaceutical giant.
A high drug failure rate is more than just a pattern recognition problem. Here's how we can address some of the root causes.
Conduit and Sarborg complete all milestones of Phase I of their AI-driven drug development collaboration, and commence transitioning to Phase II, ...
In this Pharmaceutical Executive video interview, Edoardo Madussi, Head of Business Development, Intelligencia AI discusses ...
It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US ...
Jabil has acquired contract development and manufacturing organisation (CDMO) Pharmaceutics International (Pii) to offer support for drug development customers. The acquisition of Pii enhances Jabil's ...
As the state prepares for the National Sports Festival, NSF, the Ogun State government is working to minimize and end drug ...
The stop-work order on U.S.A.I.D.-funded research has left thousands of people with experimental drugs and devices in their ...
Hundreds of thousands of doses of moxidectin – which treats a disease caused by a parasitic worm – are being given to ...
There is growing enthusiasm about China’s potential to speed up drug development with AI. And companies outside the country ...